J&J COVID-19 vaccine benefits ‘far outweigh’ risks, CDC panel says after reports of Guillain-Barré syndrome
An advisory panel to the Centers for Disease Control and Prevention (CDC) said the benefits of COVID-19 vaccines “far outweigh” potential risks amid an ongoing review of reports of a rare nerve disorder in a small fraction of J&J jab recipients.